2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
نویسندگان
چکیده
JASVINDER A. SINGH, DANIEL E. FURST, ASEEM BHARAT, JEFFREY R. CURTIS, ARTHUR F. KAVANAUGH, JOEL M. KREMER, LARRY W. MORELAND, JAMES O’DELL, KEVIN L. WINTHROP, TIMOTHY BEUKELMAN, S. LOUIS BRIDGES JR., W. WINN CHATHAM, HAROLD E. PAULUS, MARIA SUAREZ-ALMAZOR, CLAIRE BOMBARDIER, MAXIME DOUGADOS, DINESH KHANNA, CHARLES M. KING, AMYE L. LEONG, ERIC L. MATTESON, JOHN T. SCHOUSBOE, EILEEN MOYNIHAN, KAREN S. KOLBA, ARCHANA JAIN, ELIZABETH R. VOLKMANN, HARSH AGRAWAL, SANGMEE BAE, AMY S. MUDANO, NIVEDITA M. PATKAR, AND KENNETH G. SAAG
منابع مشابه
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician...
متن کاملPediatric ventricular assist devices--first steps for babies.
n engl j med 367;6 nejm.org august 9, 2012 567 tis Rheum 2009;60:1895-905. [Erratum, Arthritis Rheum 2012; 64:1487.] 10. Tanaka Y, Suzuki M, Nakamura H, Toyoizumi S, Zwillich SH. Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate. Arthritis Care Res (Hoboken) 2011;63:1150-8. 11. Ghoreschi K, Jess...
متن کاملCanadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
OBJECTIVE The Canadian Rheumatology Association (CRA) has developed recommendations for the pharmacological management of rheumatoid arthritis (RA) with traditional and biologic disease-modifying antirheumatic drugs (DMARD) in 2 parts. Part 1 is reported here. METHODS The CRA Therapeutics Committee assembled a national working group of RA clinical experts, researchers, patient consumers, and ...
متن کاملCritical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
Rheumatoid arthritis is a chronic, progressive, autoimmune disease that leads to significant disability and premature mortality. Various treatment options are available, but the foundation of treatment includes nonbiologic and biologic disease-modifying antirheumatic drugs. The incidence of patients with rheumatoid arthritis refractory to first-line agents is estimated to be at least 20%. Abata...
متن کاملIdentifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations
BACKGROUND Factors associated with care concordant with the American College of Rheumatology (ACR) recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA) are unknown. METHODS We identified a national cohort of biologic-naive patients with RA with visits between December 2008 and February 2013. Treatment acceleration (initiation or dose escal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Arthritis care & research
دوره 64 5 شماره
صفحات -
تاریخ انتشار 2012